~ Food Has Power ~
Why mandate vaccines?
In order to sell cancer vaccines (made with measles virus).
"A personalized disease like cancer requires a personalized weapon," Carson wrote in a letter to shareholders. "I believe Vaccinogen has developed the first truly personalized, and potentially commercializable, approach to combat cancer and that is why I'm joining the board and accepting the role of chairman."
Benjamin S. Carson, Sr., M.D. named Chairman of the Board of Vaccinogen in Frederick, MD.
This is telling: Nearly 300 Vaccines Are in Development.
Page 10 and beyond lists a bunch of vaccines in development.
I came across the fact that cancer vaccines are being developed using the measles virus.
"Infectious agents are present in nature that can cause cancer but we should also remember the dual role they play in preventing cancer."
"Another challenge to using measles virus (MV) therapeutically is the fact that most patients have been immunized against MV. This immunization is less of a challenge when MV is injected directly into the tumor during a neurosurgical procedure, as it is in GBM, than its systemic administration for other forms of cancer. Targeted tumor injection of MV also overcomes the effects of the blood-brain barrier."
It would seem that the ubiquitous childhood measles - which provides protection against some cancers - would be the way to decrease cancer. But, that does not optimize shareholder value.
Enter in another vaccine marketing opportunity...
"Even if one considers the worst case scenario wherein an attenuated measles virus used for cancer therapy might revert back to wild-type pathogenic strain, the risk of virus transmission from patients to caregivers and then into the population is limited by the high prevalence of anti-measles immunity.
At the current time because of the successful childhood measles vaccination programs which give lifelong protection, more than 80% of the people in the world are currently measles immune. For this reason, attenuated measles viruses raise significantly fewer safety concerns than oncolytic viruses derived from other virus families."
"The main public safety concern associated with the therapeutic use of an oncolytic virus is accidental emergence of a new viral pathogen capable of epidemic spread in the human population.[27, 28]"
Measles virus for cancer therapy.
Cancer treatment is big money
And then vaccine manufacturers claim the cancer vaccine is the "patented pharmaceutical" which saves lives - brilliant marketing.
And government vaccine mandates are necessary (to be able to sell cancer vaccines) to "protect those receiving cancer treatment" --- we've already seen that spin!